HOME >> MEDICINE >> NEWS
Interferon Significantly Affects Metabolism Of Other Drugs Given To Cancer Patients, Finds University Of Pittsburgh Cancer Institute

ATLANTA, May 17 -- Cancer patients undergoing therapy with interferon alfa 2b (IFNa2b) could be overmedicated with narcotics and antidepressants commonly administered with this agent, according to a University of Pittsburgh Cancer Institute (UPCI) study showing that IFNa2b significantly depresses the activity of internal enzymes that break down these drugs. Results of the study, which have broad implications for using IFNa2b, are being presented Monday, May 17, at the annual meeting of the American Society of Clinical Oncology (ASCO) in Atlanta.

Interferons are biological response modifiers produced naturally by the body to fight infections and tumors. IFNa2b is manufactured for use in cancer treatment studies, and it can cause flu-like symptoms and depression in people receiving it.

The study focused on patients who were surgically treated for melanoma and receiving high-dose IFNa2b to prevent recurrence of the disease. Six patients got a "cocktail" of chemicals, each of which is metabolized by a different enzyme in the family of CYP450 enzymes. CYP450 enzymes operate within the liver. Results of the study showed that IFNa2b depressed the activity of two enzymes, CYP1A2 and CYP2E1, by 30 percent. These enzymes are important in metabolizing narcotics and antidepressants given to relieve side effects of IFNa2b therapy.

"What these results tell us is that we are probably intoxicating patients when we use narcotics and antidepressants together with IFNs," said John Kirkwood, M.D., professor of medicine and director of the UPCI's Melanoma Center. "The CYP enzymes in IFNa2b-treated patients simply can't metabolize these drugs effectively, so we could probably reduce the amount of these medications we're administering during the course of IFNa2b therapy."

Dr. Kirkwood and Mohammed Islam, M.D., a research associate at UPCI who is presenting this study at the ASCO meeting, are extending their studies to other CYP enzymes involved in drug metab
'"/>

Contact: Lauren Ward
wardle@msx.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
17-May-1999


Page: 1 2

Related medicine news :

1. Interferons for treatment of SARS?
2. Interferon Alfa 2b extends overall survival and relapse-free survival in patients with high-risk melanoma, reports University of Pittsburgh-led U.S. I
3. University Of Pittsburgh Cancer Institute Defines First Immunologic Markers Of Interferon Effectiveness Against Melanoma
4. Significantly lower physical activity levels in obese adolescents contribute to continued obesity
5. Relaxation And Music Significantly Reduce Patients Postoperative Pain
6. Beta Blocker Significantly Improves Heart Failure Survival
7. Novel Therapy Significantly Reduces Spinal Fractures In Postmenopausal WomenWith Two Years Of Therapy
8. Study Reveals Gender Affects Lung-Cancer Development
9. HIV Patients Mental Health Affects How Seriously They Take Treatment
10. Other highlights in the March 16 JNCI
11. Other highlights in the March 2 JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/26/2019)... ... March 25, 2019 , ... The Dentists Insurance Company has earned the ... ratings include comparisons to peers and industry standards as well as assessments of operating ... financial strength and its mission to provide the best insurance products and related services ...
(Date:3/26/2019)... ... 26, 2019 , ... According to a new study released earlier this month ... created a last will and testament and fewer still have executed a healthcare proxy ... Enea, Scanlan & Sirignano, LLP in White Plains and Somers, N.Y., recently ...
(Date:3/25/2019)... NAPA VALLEY, Calif. (PRWEB) , ... March 25, 2019 , ... ... ERDA , Napa’s ultra-premium organic tea farm, to provide a signature wellness tea ... their cleansing and clarity-promoting properties, the blend features lemon verbena and spearmint. The Auberge ...
(Date:3/25/2019)... THE WOODLANDS, Texas (PRWEB) , ... March 25, 2019 , ... ... Air Charter Safety Symposium on March 12, 2019. The annual conference promotes ... keynote focused on how the Bradley Curve is descriptive but not prescriptive. A ...
(Date:3/24/2019)... ... 2019 , ... Few things are more painful than a toothache and a ... Robles dentist , Lisa Lu Davis, has released a report describing the various causes ... , Pain and soreness from a toothache often radiate into the entire jaw and ...
Breaking Medicine News(10 mins):
(Date:3/20/2019)... ... March 20, 2019 , ... Cognosante, ... public health agencies, today announced the appointment of Retired U.S. Army Captain, Scott ... consulting and contracts management experience supporting Federal clients, Davidson will oversee Cognosante’s new ...
(Date:3/20/2019)... Md. (PRWEB) , ... March 20, 2019 , ... ... training workshops, announced today that regenerative medicine and stem cell research pioneer Dr. ... iPSC Neural and Gene Editing iPSCs with CRISPR/Cas9 programs. The addition of Dr. ...
(Date:3/20/2019)... ... March 20, 2019 , ... ... mechanisms specifically designed to help healthcare and clinical research stakeholders around the ... and continue to lower costs by improving efficiency, promoting transparency and collaboration. ...
Breaking Medicine Technology:
Cached News: